Estabrook Capital Management Pfizer Inc Transaction History

Estabrook Capital Management

$671 Billion
Q3 2024

A detailed history of Estabrook Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Estabrook Capital Management holds 360,486 shares of PFE stock, worth $9.64 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares

360,486

Previous 361,026 0.15%

Holding current value

$9.64 Million

Previous $10.1 Billion 3.28%

% of portfolio

1.56%

Previous 1.55%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $14,958 - $16,950	-540 Reduced 0.15%	360,486 $10.4 Billion
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $28,998 - $33,980	1,148 Added 0.32%	361,026 $10.1 Billion
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $1.16 Million - $1.33 Million	44,806 Added 14.22%	359,878 $9.99 Billion
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $474,128 - $615,841	-18,145 Reduced 5.45%	315,072 $9.07 Billion
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $841,014 - $983,062	26,208 Added 8.54%	333,217 $11.1 Billion
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $21,419 - $24,781	-593 Reduced 0.19%	307,009 $11.3 Billion
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $32,339 - $42,100	-821 Reduced 0.27%	307,602 $12.6 Billion
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $136,647 - $178,378	3,273 Added 1.07%	308,423 $15.8 Billion
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $126,597 - $154,544	2,893 Added 0.96%	305,150 $13.4 Billion
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $78,635 - $93,237	-1,690 Reduced 0.56%	302,257 $15.8 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $8,692 - $10,771	190 Added 0.06%	303,947 $15.7 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $322,585 - $478,178	-7,807 Reduced 2.51%	303,757 $17.9 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $367,340 - $471,880	-9,359 Reduced 2.92%	311,564 $13.4 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $454,800 - $515,212	-12,665 Reduced 3.8%	320,923 $12.6 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $18,687 - $21,075	-558 Reduced 0.17%	333,588 $12.1 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $12,952 - $16,470	-387 Reduced 0.12%	334,146 $12.3 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $194,691 - $228,417	-6,132 Reduced 1.8%	334,533 $11.6 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $150,148 - $182,151	-4,985 Reduced 1.44%	340,665 $10.6 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $357,823 - $511,251	-13,238 Reduced 3.69%	345,650 $10.7 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $531,493 - $603,177	16,145 Added 4.71%	358,888 $13.3 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $34,114 - $44,236	-1,050 Reduced 0.31%	342,743 $11.7 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $212,006 - $238,034	-5,733 Reduced 1.64%	343,793 $0
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $83,662 - $91,917	-2,231 Reduced 0.63%	349,526 $0
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $326,225 - $371,932	-8,480 Reduced 2.35%	351,757 $14.6 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $893,600 - $1.08 Million	-25,924 Reduced 6.71%	360,237 $0
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $661,776 - $705,520	-20,066 Reduced 4.94%	386,161 $0
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $106,930 - $124,054	-3,351 Reduced 0.82%	406,227 $0
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $203,019 - $215,410	-6,104 Reduced 1.47%	409,578 $0
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $12.9 Million - $14.2 Million	415,682	415,682 $0

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Estabrook Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Estabrook Capital Management with notifications on news.

Account

Estabrook Capital Management Pfizer Inc Transaction History